Noom Launches At-Home Blood Test Kit for Metabolic Health Tracking
The new kit uses Tasso+ collection technology and certified laboratory analysis to monitor 17 health markers, including blood sugar and lipid levels.
Read MorePosted by CLP Edit Staff | May 27, 2026 | Cardiovascular, Company News, Diabetes & Metabolic Diseases |
The new kit uses Tasso+ collection technology and certified laboratory analysis to monitor 17 health markers, including blood sugar and lipid levels.
Read MorePosted by CLP Edit Staff | May 21, 2026 | Cancer, Company News, Molecular Diagnostics |
TGen has launched JAYseq, a clinical whole genome sequencing test for multiple myeloma that delivers results in 72 hours, enabling rapid identification of genetic changes and immunotherapy targets, according to the institute.
Read MorePosted by CLP Edit Staff | May 19, 2026 | Amplification Technologies, Cancer, Molecular Diagnostics |
Yourgene Health has launched the Yourgene Insight DPYD assay, expanding detection to 19 variants for DPD deficiency screening in cancer patients receiving 5-fluorouracil, with same-day results and initial Research Use Only availability.
Read MorePosted by CLP Edit Staff | May 15, 2026 | Company News, Molecular Diagnostic Analyzers, Molecular Diagnostics |
BillionToOne has launched Unity Confirm, a non-invasive prenatal test that isolates fetal cells from maternal blood to confirm high-risk screening results, addressing the gap between NIPT and invasive diagnostics.
Read MorePosted by CLP Edit Staff | May 15, 2026 | Cancer, Company News, Molecular Diagnostics |
The FDA has cleared Datar Cancer Genetics’ CellDx-Tissue, a genomic profiling assay that analyzes 517 cancer-associated genes from solid tumor tissue to support clinical decision-making, according to the company.
Read More